Clinical Trial: Long Term Treatment Strategies and Effectiveness of Secukinumab in Patient With JIA Subtypes of JPsA and ERA: Study From German BIKER Registry.

U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07190053) titled 'Long Term Treatment Strategies and Effectiveness of Secukinumab in Patient With JIA Subtypes of JPsA and ERA: Study From German BIKER Registry.' on June 12.

Brief Summary: The goal of this study is to understand the long-term treatment strategies in children and adolescents diagnosed with ERA or JPsA who received secukinumab and achieved inactive disease and to evaluate the long-term treatment effectiveness of secukinumab in the ERA or JPsA patients in the postauthorization setting.

Study Start Date: Dec., 2025

Study Type: OBSERVATIONAL

Condition: Enthesitis-related Arthritis (ERA) Juvenile Psoriatic Arthritis (JPsA)

Intervent...